Kaeberlein Matt
Department of Pathology, University of Washington, Seattle, WA, 98195-7470, USA.
Transl Med Aging. 2017 Oct;1:1-4. doi: 10.1016/j.tma.2017.09.004. Epub 2017 Sep 27.
Advances in geroscience are allowing scientists and clinicians, for the first time, to consider interventions aimed at directly targeting the hallmarks of aging. Unlike disease-specific approaches, such interventions have the potential to prevent multiple diseases of aging simultaneously, thereby greatly enhancing healthspan for most individuals. Initial clinical data indicates that geroprotective compounds such as rapamycin and metformin may be effective at delaying or reversing age-related disease in otherwise healthy elderly people and companion animals. Here I will provide an overview of the field of translational geroscience, which I believe will become the paradigm for the practice of medicine in the 21 century.
老年科学的进展使科学家和临床医生首次能够考虑直接针对衰老特征的干预措施。与针对特定疾病的方法不同,此类干预措施有可能同时预防多种老年疾病,从而极大地延长大多数人的健康寿命。初步临床数据表明,雷帕霉素和二甲双胍等老年保护化合物可能有效延缓或逆转健康老年人和伴侣动物的年龄相关疾病。在此,我将概述转化老年科学领域,我认为这将成为21世纪医学实践的典范。